Merck & Co Inc’s abstract presentation regarding KEYNOTE-426 trial at ASCO GU 2019 (16 February 2019) has confirmed that Keytruda, an anti-PD-1 therapy, in comb...

LONDON (UK) - Quanticate, a leading global data-focused clinical research organisation (CRO), has appointed of Paula Finch as senior vice president of project delive...

Despite its failure in the Phase III STELLAR-4 trial, Gilead Sciences’ lead non-alcoholic steatohepatitis (NASH) drug candidate, selonsertib, may still have a place ...

LILLE, France, February 20, 2019 / --AlzProtect, a biopharmaceutical company engaged in the development of drugs for the treatment of Alzheimer's disease and Progres...

Cambridge, UK, and Shanghai, China, February 20 2019:  Owlstone Medical Ltd., a global diagnostics company developing a breathalyzer for applications in ea...

Verisense was designed specifically to improve data quality in clinical trials, while reducing burden on sponsors, sites and participants CAMBRIDGE, MA – Feb. 19, ...